Acute hepatitis C in patients receiving hemodialysis

Renal Failure

Volumn 29, Issue 6, 2007, Pages 731-736

  Griveas, I ^a,d   Germanidis, G ^a   Visvardis, G ^a   Morice, Y ^b   Perelson, A S ^c   Pawlotsky, J M ^b   Papadopoulou, D ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b HENRI MONDOR HOSPITAL   (France)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A; VIRUS ANTIBODY; VIRUS RNA;

ACUTE HEPATITIS; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENOTYPE; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; MALE; PHYLOGENY; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE; VIROLOGY;

ACUTE DISEASE; ANTIVIRAL AGENTS; CROSS INFECTION; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RENAL DIALYSIS;

EID: 34548306786     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701460160     Document Type: Article

References (19)

1. Chan TM, Lok ASF, Cheng IKP, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology. 1993;17:5-8.
2. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV. The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med. 1990;112(12):958-960.
3. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. New Engl J Med. 1992;327:369-373.
4. Sampietro M, Badalamenti S, Salvadori S, et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence of nosocomial transmission of HCV. Kidney Int. 1995;47:911-917.
5. Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol. 1994;415-419.
6. Jaboul M, Cornu C, Van Ypersele de Strihou C, UCL Collaborative Group. Universal precautions prevent hepatitis C virus transmission: a 54 month follow up of the Belgian multicenter study. Kidney Int. 1998;53:1022-1025.
7. Geerlings W, Tufverson G, Ehrich JH, et al. Report on management of renal failure in Europe XXIII. Nephrol Dial Transplant. 1994;43:108-119.
8. Lauer GM, Walker TL, Cooper S. Acute hepatitis C. Hepatology. 2001;345:41-52.
9. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kid Dis. 2003;42:631-657.
10. Major ME, Mihalic K, Fernandez J, et al. Long term follow up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol. 1999;73:3317-3325.
11. Centers for Disease Control and Prevention. Recommendations for preventing transmission of infectious among hemodialysis patients. MMWR Morbid Mortal Wkly Rep. 2001;50:1-43.
12. Puro V, Petrosillo N, Ippolito G, for the Italian Study Group on Occupational Risk for HIV and Other Bloodborne Infections. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Am J Infect Control. 1995;23:273-277.
13. Bukh J, Miller RH, Pursell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995;15:41-63.
14. Mondelli MU, Sillini E. Clinical significance of hepatitis C virus genotypes. J Hepatol. 2000;31:65-70.
15. Silini EM, Bono F, Cividina A, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology. 1995;21:959-965.
16. Gerlach TJ, Zachoval R, Gruener N, Jung M-C, Ulsenheimer A, Schraut W, Scrirren A, et al. Acute hepatitis C: a natural course and response to antiviral treatment. Hepatology. 2001;34:341A.
17. Ohnishi K, Nomura F, Nakamo M. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status. Am J Gastroenterol. 1991;86:1041-1049.
18. Alberti A. Interferon therapy of acute hepatitis C. Viral Hepatitis Reviews. 1995;1:37-45.
19. Hoofmagle JH. Therapy for acute hepatitis C. N Engl J Med. 2001;345:1495-1497.